Orchestra BioMed
OBIO
#7811
Rank
A$0.34 B
Marketcap
$9.05
Share price
-5.96%
Change (1 day)
-17.27%
Change (1 year)

Revenue for Orchestra BioMed (OBIO)

Revenue in 2024 (TTM): A$3.15 Million

According to Orchestra BioMed 's latest financial reports the company's current revenue (TTM ) is A$3.22 Million. In 2023 the company made a revenue of A$4.05 Million a decrease over the revenue in the year 2022 that were of A$5.19 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Orchestra BioMed from 2022 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) A$3.15 M-22.24%
2023 A$4.05 M-21.97%
2022 A$5.19 M